Report: Life Sciences Job Growth Slowed Way Down in 2024
Total employment in the Massachusetts life sciences industry remained effectively flat in 2024, a key source of pressure for lab landlords.
MassBio Maps Rescue Plan for Life Science Startups
The free-flowing funding climate in biotech slowed to a trickle in 2022, choking off the supply of tenants to fill Boston’s explosion of new life science real estate.
State Lawmakers Say Cambridge ‘Maxed Out,’ Want Biotech Aid for Gateway Cities
Two Democrats who have a chance to stamp their mark on Gov. Maura Healey’s $3.5 billion plan to reinvigorate the state’s business climate want the benefits to stretch beyond the Boston metropolitan area.
Alexandria Takes Loss in Sale of Andover Property
A Lawrence buyer snapped up an Andover office building put on the market by Alexandria Real Estate Equities after just over two years of ownership.
Alexandria Sees Rebound in Lab Space Demand
Greater Boston’s largest lab landlord said vacancies in its local portfolio topped 7 percent in the fourth quarter, but a revival in life science industry expansion plans points to growth in 2024.
Alexandria Unloads Seaport Parcels After Dropping Lab Development
Alexandria Real Estate Equities sold a pair of South Boston parcels to a Boston-based investor and a self-storage facility for just over half what it paid for them.
A Career Transition Driven by Insider Knowledge
Eight years of hands-on experience in the life science world was the foundation of Jane Kepros’ career switch, where she now plays a role in shaping the next generation of research facilities.
Life Science Market Fundamentals Show Advantage Lies with Users
Dour-sounding statistics about the state of Massachusetts’ life science real estate market should be put into context. Yes, the market has short-term challenges, but it will normalize over the coming years.
Bulfinch Scraps Natick Labs for Pickleball Club
As developers rethink plans for additional life science projects, Bulfinch Cos. will swap out a planned lab conversion on hold at the Natick Mall in favor of a pickleball complex.
Lab Market Takes Another Step Back in Q3
Double-digit availability rates are the new norm for lab space in Greater Boston, with only the industry hub of East Cambridge avoiding the full force of the market downturn.
Hot Property: Biodiversity
MassBio, the industry organization that represents more than 1,600 life science and health care organizations and companies, recently began construction of its first workforce training center, Bioversity.
Biotech Group Predicts 42K New Jobs by 2032
The state’s biggest biotech landlords may be hitting pause on new developments or, in some cases, abandoning projects entirely. But those headlines haven’t dampened enthusiastic predictions from the life science industry’s leading trade group.
Hot Property: 20 Overland St.
A renovation project designed by Margulies Perruzzi transformed over 64,000 square feet across two floors at 20 Overland St. in Boston’s Fenway neighborhood into BSL-2 lab and open-plan office space.
CRE Markets Lost Ground in 2022
After continuing to ascend driven by life science industry momentum through the early stages of the COVID era, Greater Boston’s commercial real estate industry felt the gravitational pull of financial markets’ tighter lending standards and industry layoffs in 2022.
Hot Property: The 105
Dyer Brown & Assoc. designed signage and graphics at The 105 in South Boston to enhance the brand identity of tenant CRISPR Therapeutics.
Leading Biz Group: Feds Should Consider Whole Region for ARPA-H HQ
As a a group of political leaders, business groups and universities lobbies the Biden administration to pick Massachusetts to be the home of a new advanced health research agency, the New England Council last week asked the federal government to consider New England more broadly.
Biotech Tenant Demand Shrinks by 2.7M SF
A new report from commercial real estate brokerage JLL says tenant demand in Greater Boston has fallen by nearly 40 percent this year.
Biden Boosts Infrastructure, Cancer ‘Moonshot’ in Boston Trip
During his visit to Boston yesterday, President Joe Biden touted his push for a cancer “moonshot” and declared that the separate federal infrastructure law his administration is implementing will be “the most significant investment” since President Dwight D. Eisenhower.
Sublease Surge Adds Pressure on Lab Pipeline
Sublease availabilities more than doubled in the second quarter to 916,000 square feet, but commercial developers continue to play the lab card as their best bet for virtually every development site.
WATCH: Will Boston’s Lab Boom End?
Does the current softness in the life science market this actually represent a problem for developers and building owners? Banker & Tradesman spoke with a panel of experts on Aug. 29 to find out.
